The effectiveness and safety of Traumastem Biodress Disinfect

published: 13.01.2010

The eff ectiveness and safety of Traumastem Biodress Disinfect was approved during the clinical study at Privat Dermatovenerological Ward in Svidník, Slovakia. Traumastem Biodress Disinfect was tested by 15 patients with diagnosis ulcus cruris of venous origin and by diabetics with malum perforans pedis. The use of Traumastem Biodress Disinfect proved particularly effective in group of 30 patients from view of debridement and following acceleration of healing. Patients indicated pain retreat and foetor elimination which often disabled patient an inclusion in society or excluded him from a family circle.

The therapy effect: Compared to the input checkup, the epithelization after 28-days therapy was with 3 patients one third, with 9 patients it was one half and with one diabetic patient was the defect completely healed at the end of observation. Compared to input checkup, the granulation was with 3 patients one third, with 10 patients one half and with one patient with large defects it was more than three quarters.

Traumastem Biodress Disinfect not only significantly accelerates the healing process of defects of various etiology but has also a demonstrable haemostatic eff ect. It is possible to recommend the product not only for its healing qualities but also for its economic parameters. The unique composition and bioactive eff ect of Traumastem Biodress Disinfect is doubtless enrichment of therapeutic portfolio not only for dermatologist, but also for surgeon or traumatologist. The treating with these product is easy and comfortable for the patient. There is also the signifi cant analgetic effect.

Dr. Hana Zelenková Private Dermato-venereology Ward, Svidník, Slovakia